Most cited−20%
Metabolic Research
Semaglutide
GLP-1 receptor agonist reference standard for incretin-pathway research.
≥99.5%4.5(6)
from$68.00$85.00
Reference peptides used in preclinical metabolic and endocrine research — incretin receptor agonists, glucagon-family analogues and related tool compounds for in-vitro receptor and signalling work.
5 compounds